Autres langues Theraclion

Actions

ALTHE

FR0010120402

Marché Fermé - Euronext Paris Autres places de cotation 14:10:29 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,37 ^EUR	+6,02%		+2,78%	-4,64%

28/03	Theraclion : annonce une réduction de sa perte annuelle en 2023	AO
28/03	Y'a tout qui monte (sauf le risque)

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Theraclion Announces 2023 Financial Results and Continues Its Roadmap	27/03
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Theraclion : announces 2023 financial results and continues its roadmap	27/03
Theraclion : Présentation AGM – 29 juin 2023	21/12
Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	24/10/23
Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2023	11/10/23
Inner Mongolia Furui Medical Science Co., Ltd. agreed to acquire an additional 27.78% stake in Theraclion Medical Equipment Co., Ltd. from Theraclion SA for ?1	28/09/23
Theraclion : Presentation AGM 29 juin 2023	24/07/23
Theraclion : l'augmentation de capital est bouclée	23/06/23
Theraclion SA announced that it has received â‚¬8.353961 million in funding from Furui Medical Science Company Luxembourg S.Ã r.l.	22/06/23
Theraclion Names CEO	26/05/23
Theraclion Appoints Martin Deterre as CEO	25/05/23
Theraclion SA announced that it expects to receive €7 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	25/05/23
Theraclion SA announced that it expects to receive ?12.649999 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	24/05/23
Global markets live: HSBC, Logitech, Uber, IBM, BP...	02/05/23
Bolsa de Madrid: First Republic muerde el polvo a su vez	02/05/23
Theraclion SA Auditor Raises 'Going Concern' Doubt	29/04/23
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23
THERACLION : ANNOUNCES 2022 FINANCIAL RESULTS AND INFORMS ON THE COMPANY’S SHORT-TERM FINANCING	28/04/23
Theraclion : la FDA autorise une étude pivot avec Sonovein	18/04/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Theraclion

Actions

ALTHE

FR0010120402

Autres langues

Filtres